244 related articles for article (PubMed ID: 35185868)
21. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
Front Immunol; 2021; 12():716559. PubMed ID: 34335631
[TBL] [Abstract][Full Text] [Related]
22. Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation.
Shan J; Guo Y; Luo L; Lu J; Li C; Zhang C; Huang Y; Feng L; Wu W; Long D; Li S; Li Y
Cell Immunol; 2011; 270(1):5-12. PubMed ID: 21640985
[TBL] [Abstract][Full Text] [Related]
23. The Pursuit of Regulatory T Cells in the Induction of Transplant Tolerance.
Arnold PR; Li XC
Adv Exp Med Biol; 2021; 1278():273-287. PubMed ID: 33523453
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma producing regulatory T cells as a diagnostic and therapeutic tool in organ transplantation.
Daniel V; Wang H; Sadeghi M; Opelz G
Int Rev Immunol; 2014; 33(3):195-211. PubMed ID: 24266365
[TBL] [Abstract][Full Text] [Related]
25. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
Boroughs AC; Larson RC; Choi BD; Bouffard AA; Riley LS; Schiferle E; Kulkarni AS; Cetrulo CL; Ting D; Blazar BR; Demehri S; Maus MV
JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869654
[TBL] [Abstract][Full Text] [Related]
26. A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.
Mathew JM; H-Voss J; LeFever A; Konieczna I; Stratton C; He J; Huang X; Gallon L; Skaro A; Ansari MJ; Leventhal JR
Sci Rep; 2018 May; 8(1):7428. PubMed ID: 29743501
[TBL] [Abstract][Full Text] [Related]
27. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
28. The impact of Th17 cells on transplant rejection and the induction of tolerance.
Heidt S; Segundo DS; Chadha R; Wood KJ
Curr Opin Organ Transplant; 2010 Aug; 15(4):456-61. PubMed ID: 20616728
[TBL] [Abstract][Full Text] [Related]
29. Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.
López-Abente J; Martínez-Bonet M; Bernaldo-de-Quirós E; Camino M; Gil N; Panadero E; Gil-Jaurena JM; Clemente M; Urschel S; West L; Pion M; Correa-Rocha R
Sci Rep; 2021 Jan; 11(1):827. PubMed ID: 33436905
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
[TBL] [Abstract][Full Text] [Related]
31. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.
Gille I; Claas FHJ; Haasnoot GW; Heemskerk MHM; Heidt S
Front Immunol; 2022; 13():874157. PubMed ID: 35720402
[TBL] [Abstract][Full Text] [Related]
32. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
33. Tregs: application for solid-organ transplantation.
Schliesser U; Streitz M; Sawitzki B
Curr Opin Organ Transplant; 2012 Feb; 17(1):34-41. PubMed ID: 22143395
[TBL] [Abstract][Full Text] [Related]
34. CD4+ regulatory T cells in solid organ transplantation.
Issa F; Wood KJ
Curr Opin Organ Transplant; 2010 Dec; 15(6):757-64. PubMed ID: 20881492
[TBL] [Abstract][Full Text] [Related]
35. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
36. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
[TBL] [Abstract][Full Text] [Related]
37. Can proliferation signal inhibitor-induced Tregs really reflect transplantation tolerance in clinical solid organ transplantation?
Li S; Kuang A; Huang R
Int Rev Immunol; 2009; 28(5):367-75. PubMed ID: 19811315
[TBL] [Abstract][Full Text] [Related]
38. Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells.
Safinia N; Grageda N; Scottà C; Thirkell S; Fry LJ; Vaikunthanathan T; Lechler RI; Lombardi G
Front Immunol; 2018; 9():354. PubMed ID: 29535728
[TBL] [Abstract][Full Text] [Related]
39. Cell therapy to promote transplantation tolerance: a winning strategy?
Lombardi G; Sagoo P; Scotta C; Fazekasova H; Smyth L; Tsang J; Afzali B; Lechler R
Immunotherapy; 2011 Apr; 3(4 Suppl):28-31. PubMed ID: 21524166
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial.
Libetta C; Esposito P; Gregorini M; Margiotta E; Martinelli C; Borettaz I; Canevari M; Rampino T; Ticozzelli E; Abelli M; Meloni F; Dal Canton A
Transpl Immunol; 2015 Oct; 33(2):117-24. PubMed ID: 26220254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
